Lipella Pharmaceuticals Inc.: current assets

What this measure means

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Exact concept: us-gaap:AssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2021-12-31 to 2024-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Lipella Pharmaceuticals Inc.: total assets
• Lipella Pharmaceuticals Inc.: total liabilities
• Lipella Pharmaceuticals Inc.: stockholders equity
• Lipella Pharmaceuticals Inc.: cash and cash equivalents
• Lipella Pharmaceuticals Inc.: net income or loss
• Lipella Pharmaceuticals Inc.: operating cash flow
• Lipella Pharmaceuticals Inc.: revenue
• Lipella Pharmaceuticals Inc.: financing cash flow
• Lipella Pharmaceuticals Inc.: investing cash flow
• Lipella Pharmaceuticals Inc.: retained earnings or deficit
• Lipella Pharmaceuticals Inc.: basic weighted-average shares
• Lipella Pharmaceuticals Inc.: diluted weighted-average shares
• Lipella Pharmaceuticals Inc.: basic earnings per share
• Lipella Pharmaceuticals Inc.: diluted earnings per share
• Lipella Pharmaceuticals Inc.: operating income or loss
• Lipella Pharmaceuticals Inc.: interest expense
• Lipella Pharmaceuticals Inc.: current liabilities
• Lipella Pharmaceuticals Inc.: current accounts payable
• Lipella Pharmaceuticals Inc.: net current accounts receivable
• Lipella Pharmaceuticals Inc.: research and development expense
• Lipella Pharmaceuticals Inc.: common shares outstanding
• Lipella Pharmaceuticals Inc.: cash including restricted cash
• Lipella Pharmaceuticals Inc.: additional paid-in capital
• Lipella Pharmaceuticals Inc.: operating lease right-of-use asset
• Lipella Pharmaceuticals Inc.: accumulated depreciation on property, plant and equipment
• Lipella Pharmaceuticals Inc.: accrued current liabilities
• Lipella Pharmaceuticals Inc.: pre-tax income or loss from continuing operations
• Lipella Pharmaceuticals Inc.: general and administrative expense
• Lipella Pharmaceuticals Inc.: depreciation expense
• Lipella Pharmaceuticals Inc.: nonoperating income or expense
• Lipella Pharmaceuticals Inc.: change in accounts payable

Inspect the source

Entity

Lipella Pharmaceuticals Inc. / CIK 0001347242

Captured

2026-09-20T07:54:55.557Z

SEC response SHA-256

ea617e283190f994fbdca6bc66f147b2ed9f6aa48927cbdfcb6efdc52babc630

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001347242.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))